vs
Fidelity National Information Services（FIS）とTENET HEALTHCARE CORP（THC）の財務データ比較。上の社名をクリックして会社を切り替えられます
TENET HEALTHCARE CORPの直近四半期売上が大きい（$5.5B vs $2.8B、Fidelity National Information Servicesの約2.0倍）。Fidelity National Information Servicesの純利益率が高く（18.2% vs 11.7%、差は6.5%）。TENET HEALTHCARE CORPの前年同期比売上増加率が高い（9.0% vs 8.1%）。Fidelity National Information Servicesの直近四半期フリーキャッシュフローが多い（$739.0M vs $367.0M）。過去8四半期でFidelity National Information Servicesの売上複合成長率が高い（6.8% vs 1.5%）
Fidelity National Information Services（FIS）は米国発の多国籍企業で、金融テクノロジー分野を主力として多様な金融商品・サービスを提供しています。年間約750億件の取引を処理し、約9兆米ドルの資金移動を支援し、世界2万社以上の顧客にサービスを展開しています。
テネット・ヘルスケア・コーポレーションは米国ダラスに本社を置く営利目的の多国籍医療サービス企業です。USPIをはじめとするブランド・子会社・合弁事業・提携先を通じ、65の病院と450以上の医療施設を運営するほか、Conifer Health Solutionsで医療システムなどの顧客向けに医療支援サービスを提供しています
FIS vs THC — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $2.8B | $5.5B |
| 純利益 | $511.0M | $644.0M |
| 粗利率 | 38.3% | — |
| 営業利益率 | 18.8% | 15.4% |
| 純利益率 | 18.2% | 11.7% |
| 売上前年比 | 8.1% | 9.0% |
| 純利益前年比 | 97.3% | 12.6% |
| EPS（希薄化後） | $0.98 | $4.22 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $2.8B | $5.5B | ||
| Q3 25 | $2.7B | $5.3B | ||
| Q2 25 | $2.6B | $5.3B | ||
| Q1 25 | $2.5B | $5.2B | ||
| Q4 24 | $2.6B | $5.1B | ||
| Q3 24 | $2.6B | $5.1B | ||
| Q2 24 | $2.5B | $5.1B | ||
| Q1 24 | $2.5B | $5.4B |
| Q4 25 | $511.0M | $644.0M | ||
| Q3 25 | $264.0M | $579.0M | ||
| Q2 25 | $-470.0M | $522.0M | ||
| Q1 25 | $77.0M | $622.0M | ||
| Q4 24 | $259.0M | $572.0M | ||
| Q3 24 | $224.0M | $681.0M | ||
| Q2 24 | $243.0M | $477.0M | ||
| Q1 24 | $724.0M | $2.3B |
| Q4 25 | 38.3% | — | ||
| Q3 25 | 37.8% | — | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 34.7% | — | ||
| Q4 24 | 36.9% | — | ||
| Q3 24 | 38.0% | — | ||
| Q2 24 | 38.2% | — | ||
| Q1 24 | 37.1% | — |
| Q4 25 | 18.8% | 15.4% | ||
| Q3 25 | 16.8% | 16.8% | ||
| Q2 25 | 15.6% | 15.6% | ||
| Q1 25 | 13.7% | 18.1% | ||
| Q4 24 | 18.5% | 16.2% | ||
| Q3 24 | 19.1% | 21.3% | ||
| Q2 24 | 15.2% | 14.9% | ||
| Q1 24 | 14.6% | 61.2% |
| Q4 25 | 18.2% | 11.7% | ||
| Q3 25 | 9.7% | 10.9% | ||
| Q2 25 | -18.0% | 9.9% | ||
| Q1 25 | 3.0% | 11.9% | ||
| Q4 24 | 10.0% | 11.3% | ||
| Q3 24 | 8.7% | 13.3% | ||
| Q2 24 | 9.8% | 9.3% | ||
| Q1 24 | 29.3% | 43.5% |
| Q4 25 | $0.98 | $4.22 | ||
| Q3 25 | $0.50 | $3.86 | ||
| Q2 25 | $-0.90 | $3.14 | ||
| Q1 25 | $0.15 | $4.27 | ||
| Q4 24 | $0.51 | $3.79 | ||
| Q3 24 | $0.41 | $4.89 | ||
| Q2 24 | $0.44 | $2.64 | ||
| Q1 24 | $1.25 | $21.38 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $599.0M | $2.9B |
| 総負債低いほど良い | $9.1B | $13.1B |
| 株主資本純資産 | $13.9B | $4.2B |
| 総資産 | $33.5B | $29.7B |
| 負債/資本比率低いほどレバレッジが低い | 0.65× | 3.10× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $599.0M | $2.9B | ||
| Q3 25 | $571.0M | $3.0B | ||
| Q2 25 | $581.0M | $2.6B | ||
| Q1 25 | $805.0M | $3.0B | ||
| Q4 24 | $834.0M | $3.0B | ||
| Q3 24 | $1.3B | $4.1B | ||
| Q2 24 | $2.1B | $2.9B | ||
| Q1 24 | $3.3B | $2.5B |
| Q4 25 | $9.1B | $13.1B | ||
| Q3 25 | $8.9B | $13.1B | ||
| Q2 25 | $8.9B | $13.1B | ||
| Q1 25 | $8.7B | $13.1B | ||
| Q4 24 | $9.7B | $13.1B | ||
| Q3 24 | $10.5B | $12.8B | ||
| Q2 24 | $10.6B | $12.8B | ||
| Q1 24 | $10.6B | $12.8B |
| Q4 25 | $13.9B | $4.2B | ||
| Q3 25 | $13.9B | $4.0B | ||
| Q2 25 | $14.2B | $3.7B | ||
| Q1 25 | $15.1B | $4.2B | ||
| Q4 24 | $15.7B | $4.2B | ||
| Q3 24 | $16.6B | $3.8B | ||
| Q2 24 | $17.0B | $3.5B | ||
| Q1 24 | $18.0B | $3.5B |
| Q4 25 | $33.5B | $29.7B | ||
| Q3 25 | $33.0B | $29.4B | ||
| Q2 25 | $33.4B | $28.7B | ||
| Q1 25 | $32.8B | $29.2B | ||
| Q4 24 | $33.8B | $28.9B | ||
| Q3 24 | $34.3B | $29.4B | ||
| Q2 24 | $34.6B | $29.3B | ||
| Q1 24 | $35.9B | $28.9B |
| Q4 25 | 0.65× | 3.10× | ||
| Q3 25 | 0.64× | 3.26× | ||
| Q2 25 | 0.63× | 3.49× | ||
| Q1 25 | 0.57× | 3.13× | ||
| Q4 24 | 0.62× | 3.14× | ||
| Q3 24 | 0.63× | 3.33× | ||
| Q2 24 | 0.62× | 3.67× | ||
| Q1 24 | 0.59× | 3.70× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $758.0M | $731.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $739.0M | $367.0M |
| FCFマージンFCF / 売上 | 26.3% | 6.6% |
| 設備投資強度設備投資 / 売上 | 0.7% | 6.6% |
| キャッシュ転換率営業CF / 純利益 | 1.48× | 1.14× |
| 直近12ヶ月FCF直近4四半期 | $2.5B | $2.5B |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $758.0M | $731.0M | ||
| Q3 25 | $1.0B | $1.1B | ||
| Q2 25 | $382.0M | $936.0M | ||
| Q1 25 | $457.0M | $815.0M | ||
| Q4 24 | $782.0M | $-331.0M | ||
| Q3 24 | $641.0M | $1.0B | ||
| Q2 24 | $546.0M | $747.0M | ||
| Q1 24 | $206.0M | $586.0M |
| Q4 25 | $739.0M | $367.0M | ||
| Q3 25 | $952.0M | $778.0M | ||
| Q2 25 | $343.0M | $743.0M | ||
| Q1 25 | $420.0M | $642.0M | ||
| Q4 24 | $764.0M | $-661.0M | ||
| Q3 24 | $605.0M | $829.0M | ||
| Q2 24 | $530.0M | $602.0M | ||
| Q1 24 | $179.0M | $346.0M |
| Q4 25 | 26.3% | 6.6% | ||
| Q3 25 | 35.0% | 14.7% | ||
| Q2 25 | 13.1% | 14.1% | ||
| Q1 25 | 16.6% | 12.3% | ||
| Q4 24 | 29.4% | -13.0% | ||
| Q3 24 | 23.5% | 16.2% | ||
| Q2 24 | 21.3% | 11.8% | ||
| Q1 24 | 7.3% | 6.4% |
| Q4 25 | 0.7% | 6.6% | ||
| Q3 25 | 2.2% | 5.3% | ||
| Q2 25 | 1.5% | 3.7% | ||
| Q1 25 | 1.5% | 3.3% | ||
| Q4 24 | 0.7% | 6.5% | ||
| Q3 24 | 1.4% | 4.2% | ||
| Q2 24 | 0.6% | 2.8% | ||
| Q1 24 | 1.1% | 4.5% |
| Q4 25 | 1.48× | 1.14× | ||
| Q3 25 | 3.83× | 1.83× | ||
| Q2 25 | — | 1.79× | ||
| Q1 25 | 5.94× | 1.31× | ||
| Q4 24 | 3.02× | -0.58× | ||
| Q3 24 | 2.86× | 1.53× | ||
| Q2 24 | 2.25× | 1.57× | ||
| Q1 24 | 0.28× | 0.25× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
FIS
| Banking Solutions | $1.6B | 57% |
| Other | $701.0M | 25% |
| Capital Market Solutions | $508.0M | 18% |
THC
| Other | $2.9B | 52% |
| Health Care Patient Service | $1.4B | 25% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $1.2B | 22% |
| Health Care Other Sources | $56.0M | 1% |
